A novel analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable, according to a study from researchers at Weill Cornell Medicine and the New York Genome Center.
The Sandra and Edward Meyer Cancer Center of Weill Cornell Medicine and New York-Presbyterian Hospital has appointed a trio of physicians and researchers to oversee the center’s first Office of Diversity Equity and Inclusion: Eloise Chapman-Davis, Minerva A. Romero Arenas, and Monica L. Guzman.
